ProPhase Labs enters $1M bridge loan (20% OID) from CEO and investor; issues warrants

ProPhase Labs, Inc.

Each loan (CEO and investor) $500k principal, 20% OID ($625k face), 10% interest, 12-month maturity.
Company issued 500,000 unvested warrants per loan (1M total) at $0.60/share, vesting conditional on shareholder approval.
Loans secured but subordinate to up to $6M senior debt; proceeds for working capital; repayment via Nebula Genomics sale or Crown Medical collections.
CEO loan is related-party transaction; Audit Committee approved; Karkus receives $10,000 expense reimbursement.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.